Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Hall

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
BMC Genomics|January 26, 2022
Correction to: Long read sequencing reveals novel isoforms and insights into splicing regulation during cell state changesDavid J Wright, Nicola A L Hall, Naomi Irish, et al.
BMC Genomics|January 11, 2022
Long read sequencing reveals novel isoforms and insights into splicing regulation during cell state changesDavid J Wright, Nicola A L Hall, Naomi Irish, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 10, 2024
Identification and characterization of human KALRN mRNA and Kalirin protein isoformsArne W Mould, David J Wright, Klaus D Bornemann, et al.
Research Square|December 3, 2025
Timothy Syndrome and CACNA1C-Related Disorder: First International Language and Management Guidelines Consensus StatementJack F G Underwood, Katherine W Timothy, Holly Tyroll, et al.
British Journal of Cancer|December 2, 2010
Hand pattern indicates prostate cancer riskA A Rahman, A Lophatananon, S Stewart-Brown, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levelsSamuel A L Hall, Gareth S Burns, Despina Anagnostou, et al.
British Journal of Cancer|August 26, 2010
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosisS M Edwards, D G R Evans, Q Hope, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2024
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapySimon J Hume, Danny K Wong, Man-Fung Yuen, et al.
The Journal of Infectious Diseases|September 15, 2022
Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling PathwaysSamuel A L Hall, Gareth S Burns, Benjamin J Mooney, et al.
Hepatology Communications|July 17, 2023
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participantsAlexander J Thompson, Kathy Jackson, Sara Bonanzinga, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
BMC Genomics|January 26, 2022
Correction to: Long read sequencing reveals novel isoforms and insights into splicing regulation during cell state changesDavid J Wright, Nicola A L Hall, Naomi Irish, et al.
BMC Genomics|January 11, 2022
Long read sequencing reveals novel isoforms and insights into splicing regulation during cell state changesDavid J Wright, Nicola A L Hall, Naomi Irish, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 10, 2024
Identification and characterization of human KALRN mRNA and Kalirin protein isoformsArne W Mould, David J Wright, Klaus D Bornemann, et al.
Research Square|December 3, 2025
Timothy Syndrome and CACNA1C-Related Disorder: First International Language and Management Guidelines Consensus StatementJack F G Underwood, Katherine W Timothy, Holly Tyroll, et al.
British Journal of Cancer|December 2, 2010
Hand pattern indicates prostate cancer riskA A Rahman, A Lophatananon, S Stewart-Brown, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2022
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levelsSamuel A L Hall, Gareth S Burns, Despina Anagnostou, et al.
British Journal of Cancer|August 26, 2010
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosisS M Edwards, D G R Evans, Q Hope, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 15, 2024
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapySimon J Hume, Danny K Wong, Man-Fung Yuen, et al.
The Journal of Infectious Diseases|September 15, 2022
Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling PathwaysSamuel A L Hall, Gareth S Burns, Benjamin J Mooney, et al.
Hepatology Communications|July 17, 2023
Baseline serum HBV RNA is associated with the risk of hepatitis flare after stopping nucleoside analog therapy in HBeAg-negative participantsAlexander J Thompson, Kathy Jackson, Sara Bonanzinga, et al.
Pageof 7